Εμφάνιση απλής εγγραφής

dc.creatorLiaskos, C.en
dc.creatorMavropoulos, A.en
dc.creatorOrfanidou, T.en
dc.creatorSpyrou, V.en
dc.creatorAthanasiou, L. V.en
dc.creatorBillinis, C.en
dc.date.accessioned2015-11-23T10:37:57Z
dc.date.available2015-11-23T10:37:57Z
dc.date.issued2012
dc.identifier10.1007/s13317-012-0036-1
dc.identifier.issn20380305
dc.identifier.urihttp://hdl.handle.net/11615/30332
dc.description.abstractAutoimmune hepatitis (AIH) is not a disease entity restricted to man, but it can be found in other animals including canines. An increasing number of studies have focused on the immunopathogenesis of human autoimmune hepatitis (hAIH), but little is known of what triggers canine autoimmune hepatitis (cAIH). Several drugs, toxins, microbial and viral agents are able to induce autoantibodies and indeed immune-mediated chronic canine hepatitis with immunological and serological features similar of those seen in the human disease. We discuss the features of cAIH paying attention to the autoantibody profile of the disease in comparison to that seen in hAIH. We also discuss the immunomodulatory role of specific molecular signaling pathways such as those mediated by tumor growth factor and p38 mitogen-activated kinase in the induction of AIH, and the potential of these molecules to act as targets of specialized immunotherapeutic interventions. Review of the literature indicates that we have more to learn for the delineation of autoantibody profile and the antigen-specific immunoregulatory mechanisms involved in the pathogenesis of cAIH from the human disease, rather than the other way around. © 2012 Springer-Verlag Italia.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-84870509433&partnerID=40&md5=d6bbd2252583e901a57359f1e91721d8
dc.subjectAutoimmuneen
dc.subjectDogen
dc.subjectHepatitisen
dc.subjectHumanen
dc.subjectalcoholen
dc.subjectalpha 1 antitrypsinen
dc.subjectanticonvulsive agenten
dc.subjectantiliver cytosol type 1en
dc.subjectantiliver kidney microsome antibody type 1en
dc.subjectantinuclear antibodyen
dc.subjectautoantibodyen
dc.subjectcancer growth factoren
dc.subjectimmunosuppressive agenten
dc.subjectmicrosome antibodyen
dc.subjectmitogen activated protein kinase p38en
dc.subjectsmooth muscle antibodyen
dc.subjectunclassified drugen
dc.subjectalpha 1 antitrypsin deficiencyen
dc.subjectautoimmune hepatitisen
dc.subjectchronic liver diseaseen
dc.subjectclinical featureen
dc.subjectcopper storage diseaseen
dc.subjectdisease activityen
dc.subjectdisease courseen
dc.subjectdisease severityen
dc.subjectdog diseaseen
dc.subjectenzyme activationen
dc.subjectgenetic disorderen
dc.subjectHepatitis A virusen
dc.subjectHepatitis B virusen
dc.subjectHepatitis C virusen
dc.subjectHepatitis delta virusen
dc.subjectHepatitis E virusen
dc.subjectimmune responseen
dc.subjectimmunomodulationen
dc.subjectimmunopathogenesisen
dc.subjectimmunopathologyen
dc.subjectimmunoregulationen
dc.subjectintracellular signalingen
dc.subjectliver cirrhosisen
dc.subjectmetabolic disorderen
dc.subjectmicroorganismen
dc.subjectnonhumanen
dc.subjectpriority journalen
dc.subjectprotein analysisen
dc.subjectprotein functionen
dc.subjectprotein targetingen
dc.subjectreviewen
dc.subjectrisk assessmenten
dc.subjectrisk factoren
dc.subjectserologyen
dc.subjectvirusen
dc.subjectvirus cell interactionen
dc.subjectvirus hepatitisen
dc.subjectvirus isolationen
dc.titleThe immunopathogenetic role of autoantibodies in canine autoimmune hepatitis: Lessons to learn from human autoimmune hepatitisen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής